Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Apotex Research Private Limited (ARPL) is a significant subsidiary of Apotex Inc., Canada's largest producer of generic pharmaceuticals. Based in Bangalore, India, the company serves as a global hub for research, development, and manufacturing, focusing on high-quality generic formulations for international markets including the US, Canada, and Europe. ARPL operates advanced R&D centers and state-of-the-art manufacturing facilities that are compliant with global regulatory standards such as the US FDA and Health Canada. The company's portfolio spans a wide range of therapeutic areas, including cardiovascular, central nervous system, and metabolic diseases. By leveraging cost-effective Indian operations with stringent global quality standards, Apotex Research plays a critical role in the parent company's mission to provide affordable healthcare solutions worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Apotex Research.